• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EMT 在乳腺癌干细胞生成中的作用。

EMT in breast cancer stem cell generation.

机构信息

INSERM UMR 1052, Lyon, France.

出版信息

Cancer Lett. 2013 Sep 10;338(1):63-8. doi: 10.1016/j.canlet.2012.05.014. Epub 2012 May 22.

DOI:10.1016/j.canlet.2012.05.014
PMID:22634497
Abstract

The concept of cancer stem cells (CSCs) has been proposed to explain the ability of single disseminated cancer cells to reconstitute tumours with heterogeneity similar to that of the primary tumour they arise from. Although this concept is now commonly accepted, the origin of these CSCs remains a source of debate. First proposed to arise through stem/progenitor cell transformation, CSCs might also or alternatively arise from differentiated cancer cells through epithelial to mesenchymal transition (EMT), an embryonic transdifferentiation process. Using breast carcinomas as a study model, I propose revisiting the role of EMT in generating CSCs and the debate on potential underlying mechanisms and biological significance.

摘要

癌症干细胞(CSC)的概念已经被提出,用于解释单个分散的癌细胞重新构成肿瘤的能力,其异质性与它们起源的原发性肿瘤相似。尽管这个概念现在已经被普遍接受,但这些 CSC 的起源仍然是一个争论的来源。CSC 最初被提出是通过干细胞/祖细胞转化而来,也可能或者通过上皮到间充质转化(EMT)从分化的癌细胞中产生,这是一个胚胎转分化过程。我使用乳腺癌作为研究模型,提出重新审视 EMT 在产生 CSC 中的作用以及关于潜在机制和生物学意义的争论。

相似文献

1
EMT in breast cancer stem cell generation.EMT 在乳腺癌干细胞生成中的作用。
Cancer Lett. 2013 Sep 10;338(1):63-8. doi: 10.1016/j.canlet.2012.05.014. Epub 2012 May 22.
2
Cancer stem cell: fundamental experimental pathological concepts and updates.癌症干细胞:基本实验病理学概念及进展
Exp Mol Pathol. 2015 Apr;98(2):184-91. doi: 10.1016/j.yexmp.2015.02.002. Epub 2015 Feb 7.
3
Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.上皮间质转化:对乳腺癌干细胞和耐药性的影响。
Cancer Treat Rev. 2014 Apr;40(3):341-8. doi: 10.1016/j.ctrv.2013.09.008. Epub 2013 Sep 15.
4
Inflammation linking EMT and cancer stem cells.炎症连接 EMT 和癌症干细胞。
Oral Oncol. 2012 Nov;48(11):1068-75. doi: 10.1016/j.oraloncology.2012.06.005. Epub 2012 Jul 4.
5
Mechanisms promoting physiological cells progression into tumorigenesis.促进生理细胞向癌变发展的机制。
J Physiol Pharmacol. 2012 Dec;63(6):565-70.
6
Breast-cancer stem cells-beyond semantics.乳腺癌干细胞——超越语义学。
Lancet Oncol. 2012 Jan;13(1):e43-8. doi: 10.1016/S1470-2045(11)70191-7.
7
Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.将 SV40ER 和 hTERT 导入乳腺球体可产生具有干细胞特性的乳腺癌细胞。
Oncogene. 2012 Apr 12;31(15):1896-909. doi: 10.1038/onc.2011.378. Epub 2011 Aug 29.
8
MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.涉及调节上皮-间充质转化和癌症干细胞的 microRNAs 作为癌症治疗的分子靶标。
Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14.
9
Breast cancer stem cells: obstacles to therapy.乳腺癌干细胞:治疗的障碍。
Cancer Lett. 2013 Sep 10;338(1):57-62. doi: 10.1016/j.canlet.2012.04.023. Epub 2012 Apr 30.
10
Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.乳腺癌干细胞与上皮间质可塑性——对化疗耐药性的影响。
Cancer Lett. 2013 Nov 28;341(1):56-62. doi: 10.1016/j.canlet.2013.06.003. Epub 2013 Jul 2.

引用本文的文献

1
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer.克服乳腺癌耐药性的潜在机制与新兴策略
Cancers (Basel). 2025 Sep 8;17(17):2938. doi: 10.3390/cancers17172938.
2
[Epithelial-mesenchymal Transition: Biological Basis and Clinical Prospects 
of Lung Cancer Invasion, Metastasis, and Drug Resistance].[上皮-间质转化:肺癌侵袭、转移及耐药的生物学基础与临床前景]
Zhongguo Fei Ai Za Zhi. 2025 Feb 20;28(2):155-164. doi: 10.3779/j.issn.1009-3419.2025.102.07.
3
Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications.
矿化生物标志物在乳腺癌钙化以外结局中的意义。
Int J Mol Sci. 2025 Jan 14;26(2):645. doi: 10.3390/ijms26020645.
4
TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway.TSP50 通过 PI3K p110α 介导的 AKT 信号通路激活促进乳腺癌干细胞样特性维持和上皮-间充质转化。
J Exp Clin Cancer Res. 2024 Jul 20;43(1):201. doi: 10.1186/s13046-024-03118-4.
5
The Significance of Cancer Stem Cells and Epithelial-Mesenchymal Transition in Metastasis and Anti-Cancer Therapy.癌症干细胞和上皮-间质转化在转移和抗癌治疗中的意义。
Int J Mol Sci. 2023 Jan 29;24(3):2555. doi: 10.3390/ijms24032555.
6
FYN: emerging biological roles and potential therapeutic targets in cancer.FYN:癌症中新兴的生物学作用和潜在治疗靶点。
J Transl Med. 2023 Feb 5;21(1):84. doi: 10.1186/s12967-023-03930-0.
7
MicroRNAs as a clue to overcome breast cancer treatment resistance.微小 RNA 作为克服乳腺癌治疗耐药性的线索。
Cancer Metastasis Rev. 2022 Mar;41(1):77-105. doi: 10.1007/s10555-021-09992-0. Epub 2021 Sep 15.
8
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.针对癌症干性相关信号通路的治疗靶向作用
Front Oncol. 2020 Aug 26;10:1533. doi: 10.3389/fonc.2020.01533. eCollection 2020.
9
Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells.DLK1-DIO3基因座上非编码RNA的表达与乳腺上皮祖细胞的基底和间充质表型相关。
Front Cell Dev Biol. 2020 Jun 16;8:461. doi: 10.3389/fcell.2020.00461. eCollection 2020.
10
Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway.纳布啡通过 AKT-NFκB 信号通路抑制乳腺癌干细胞样特性和上皮-间充质转化。
J Exp Clin Cancer Res. 2019 May 15;38(1):197. doi: 10.1186/s13046-019-1184-1.